Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Phase 3 trials are still running, and Eli Lilly is expected to submit retatrutide for regulatory approval once the remaining trials report results across 2026
Melanotan-2 vs PT-141: Research Application Comparison Key Takeaways Melanotan-2 binds all five melanocortin receptor subtypes non-selectively, producing simultaneous tanning, appetite suppression, and sexual effects
The menstrual effects are related to weight loss and insulin sensitivity, not formulation differences
3 Additionally, a case series of 3 patients (2 female, 1 male
Doctor-Formulated for Real Results
US$ 26.08
US$ 23.74
US$ 22.22
